Meeting Abstract


DOI :10.26650/JARHS2021-1138032   IUP :10.26650/JARHS2021-1138032    Full Text (PDF)

DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY

Güneş Esendağlı

Checkpoint blockade immunotherapy relies on the restoration of effector responses in precursor-exhausted T cells. Nevertheless, many inhibitory receptors are upregulated soon after the activation and reach high levels at effector phases. In addition to the functional status of type 1 helper T (Th1) cells, the timing and duration of PD-1 and CTLA-4 blockade are considered as critical factors for retaining T cell responsiveness. Here, we used a previously established ex-vivo model to display the decline in Th1 responses and to determine the state-of-function which may critically modulate the success of checkpoint blockade. In the absence of PD-1 and/or CTLA-4 blockade, proliferation and IFN-γ, TNF-α, IL-2 secretion capacities of Th1 cells were gradually abolished as the stimulation was continued. When applied at an early activation stage, the extension of blockade period interfered with the upregulation of multiple inhibitory receptors (PD-1, LAG3, TIM-3, and CTLA-4) and restricted Th1 hyporesponsiveness. The inhibitory receptors that were already expressed prior to the blockade were also downregulated potentially through an endocytic pathway. A time point representing the late stages of effector Th1 responses, which preceded the exhaustion, was determined as a therapeutic window for a short-term check point blockade. In conclusion, PD-1 and CTLA-4 checkpoint inhibitor therapy not only adjust the reactivation of hyporesponsive T cells but can also restrict the induction of de novo T cell exhaustion.


PDF View

References

    Citations

    Copy and paste a formatted citation or use one of the options to export in your chosen format


    EXPORT



    APA

    Esendağlı, G. (2022). DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Journal of Advanced Research in Health Sciences, 5(1), 23-23. https://doi.org/10.26650/JARHS2021-1138032


    AMA

    Esendağlı G. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Journal of Advanced Research in Health Sciences. 2022;5(1):23-23. https://doi.org/10.26650/JARHS2021-1138032


    ABNT

    Esendağlı, G. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 5, n. 1, p. 23-23, 2022.


    Chicago: Author-Date Style

    Esendağlı, Güneş,. 2022. “DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY.” Journal of Advanced Research in Health Sciences 5, no. 1: 23-23. https://doi.org/10.26650/JARHS2021-1138032


    Chicago: Humanities Style

    Esendağlı, Güneş,. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY.” Journal of Advanced Research in Health Sciences 5, no. 1 (Feb. 2024): 23-23. https://doi.org/10.26650/JARHS2021-1138032


    Harvard: Australian Style

    Esendağlı, G 2022, 'DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY', Journal of Advanced Research in Health Sciences, vol. 5, no. 1, pp. 23-23, viewed 24 Feb. 2024, https://doi.org/10.26650/JARHS2021-1138032


    Harvard: Author-Date Style

    Esendağlı, G. (2022) ‘DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY’, Journal of Advanced Research in Health Sciences, 5(1), pp. 23-23. https://doi.org/10.26650/JARHS2021-1138032 (24 Feb. 2024).


    MLA

    Esendağlı, Güneş,. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY.” Journal of Advanced Research in Health Sciences, vol. 5, no. 1, 2022, pp. 23-23. [Database Container], https://doi.org/10.26650/JARHS2021-1138032


    Vancouver

    Esendağlı G. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY. Journal of Advanced Research in Health Sciences [Internet]. 24 Feb. 2024 [cited 24 Feb. 2024];5(1):23-23. Available from: https://doi.org/10.26650/JARHS2021-1138032 doi: 10.26650/JARHS2021-1138032


    ISNAD

    Esendağlı, Güneş. DISSECTION OF T CELL ACTIVATION PHASES FOR CHECK POINT BLOCKADE IMMUNOTHERAPY”. Journal of Advanced Research in Health Sciences 5/1 (Feb. 2024): 23-23. https://doi.org/10.26650/JARHS2021-1138032



    TIMELINE


    Published Online09.08.2022

    LICENCE


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    SHARE




    Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.